Yes it’s North American Spine Society (NASS) Week, an annual congress that is always accompanied by a flurry of product launches and clinical results.
One company keen to enjoy the NASS 2016 moment is Vertera Spine, a developer of medical devices using advanced biomaterial technologies. Vertera has announced the first early successful outcomes using the COHERE Cervical Interbody Fusion Device, the company’s first device featuring its patented porous PEEK (polyetherether ketone) Scoria biomaterial technology. Scoria’s porous architecture seamlessly integrates with the bulk PEEK implant providing an environment for bony tissue ingrowth while retaining the mechanical and imaging properties of traditional PEEK implants.
Studies have demonstrated that porous implants are able to generate a stronger osteogenic cellular response and better osseointegrate over implants with micro- and nano-roughness. While porous metal or porous metal-coated PEEK implants have found their way into spinal fusion applications, COHERE is the first device in clinical use to be manufactured entirely out of PEEK and contain porosity. Because there is no metal, COHERE also provides the additional advantage of not producing any medical imaging artifacts, allowing accurate visualization of the fusion site.
Since its initial soft launch in May 2016, over 400 COHERE devices have been implanted in anterior cervical fusion surgeries by a select number of surgeons across the United States. Dr. Robert McGuire, Past Chairman of AO Spine North America and from the University of Mississippi Medical Center in Jackson, Miss., was one of the first surgeons to use the COHERE implant.
“I have been very pleased with the early outcomes I am seeing with the COHERE device,” said Dr. McGuire. “There has been a clinical need for a porous PEEK fusion device that addresses the limited integration capabilities of traditional PEEK devices. I am excited to adopt COHERE into my practice.”
Dr. Clint Hill (The Orthopaedic Institute in Paducah, Kentucky), another soft launch COHERE user, has several several patients at 5 months post-surgery.
“COHERE with its porous PEEK architecture is the first of its kind to offer an osteoconductive environment without the use of metal. With all my patients who have received a COHERE device, I am observing early signs of fusion with significant bony bridging,” said Dr. Hill
Likewise, Dr. Brandon Strenge, also from the Orthopaedic Institute in Kentucky, has implanted several COHERE devices and is observing similar outcomes at almost 5-months post-surgery.
“The hydrophilic nature and ingrowth capability of COHERE’s porous architecture gives me the confidence that fusion can be achieved even in more challenging multi-level cases,” said Dr. Strenge. “Porous PEEK Scoria is a game-changing technology that will make all other PEEK devices obsolete and could lend itself to many future applications.”
Source: Vertera Spine